Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways

  • Naziia Kurmasheva
  • , Aida Said
  • , Boaz Wong
  • , Priscilla Kinderman
  • , Xiaoying Han
  • , Anna H.F. Rahimic
  • , Alena Kress
  • , Madalina E. Carter-Timofte
  • , Emilia Holm
  • , Demi van der Horst
  • , Christoph F. Kollmann
  • , Zhenlong Liu
  • , Chen Wang
  • , Huy-Dung Hoang
  • , Elina Kovalenko
  • , Maria Chrysopoulou
  • , Krishna Sundar Twayana
  • , Rasmus N Ottosen
  • , Esben B. Svenningsen
  • , Fabio Begnini
  • Anders E. Kiib, Florian E.H. Kromm, Hauke J. Weiss, Daniele Di Carlo, Michela Muscolini, Maureen Higgins, Mirte van der Heijden, Rozanne Arulanandam, Angelina Bardoul, Tong Tong, Attila Ozsvar, Wen-Hsien Hou, Vivien R. Schack, Christian K. Holm, Yunan Zheng, Melanie Ruzek, Joanna Kalucka, Laureano de la Vega, Walid A.M. Elgaher, Anders R. Korshoej, Rongtuan Lin, John Hiscott, Thomas B. Poulsen, Luke A. O'Neill, Dominic G Roy, Markus M. Rinschen, Nadine van Montfoort, Jean-Simon Diallo, Henner F Farin, Tommy Alain, David Olagnier (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

25 Downloads (Pure)

Abstract

Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-48422-x, published online 15 May 2024 The original version of this Article omitted from the author list the 28th author Rozanne Arulanandam, who is from the ‘Ottawa Hospital Research Insitute, Ottawa, ON, K1H 8L6, Canada’. Consequently, the following was added to the Author Contributions: ‘R.A. performed the revision experiments on cell lines shown in Figures 1 and 2, in particular, the virus titration and GFP measurements of virus infection in CT26wt and 76-9 with 4OI.’ The original version of this Article omitted funding details to R.L. The following was added to the Acknowledgements: ‘This research was supported by grants to R.L. from the Canadian Institutes of Health Research (CIHR) (PJT-169663).’ These have been corrected in both the PDF and HTML versions of the Article.

Original languageEnglish
Article number10698
Number of pages1
JournalNature Communications
Volume15
DOIs
Publication statusPublished - 19 Dec 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • General Chemistry
  • General Biochemistry,Genetics and Molecular Biology
  • General Physics and Astronomy

Fingerprint

Dive into the research topics of 'Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways'. Together they form a unique fingerprint.
  • Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways

    Kurmasheva, N., Said, A., Wong, B., Kinderman, P., Han, X., Rahimic, A. H. F., Kress, A., Carter-Timofte, M. E., Holm, E., van der Horst, D., Kollmann, C. F., Liu, Z., Wang, C., Hoang, H.-D., Kovalenko, E., Chrysopoulou, M., Twayana, K. S., Ottosen, R. N., Svenningsen, E. B. & Begnini, F. & 31 others, Kiib, A. E., Kromm, F. E. H., Weiss, H. J., Di Carlo, D., Muscolini, M., Higgins, M., van der Heijden, M., Arulanandam, R., Bardoul, A., Tong, T., Ozsvar, A., Hou, W.-H., Schack, V. R., Holm, C. K., Zheng, Y., Ruzek, M., Kalucka, J., de la Vega, L., Elgaher, W. A. M., Korshoej, A. R., Lin, R., Hiscott, J., Poulsen, T. B., O'Neill, L. A., Roy, D. G., Rinschen, M. M., van Montfoort, N., Diallo, J.-S., Farin, H. F., Alain, T. & Olagnier, D. (Lead / Corresponding author), 15 May 2024, In: Nature Communications. 15, 1, 28 p., 4096.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    File
    186 Downloads (Pure)

Cite this